<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>Cancer Luminaries</title>
    <atom:link href="https://feed.podbean.com/cancer-luminaries/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://cancer-luminaries.podbean.com</link>
    <description><![CDATA[<div>Season 2 of <em>Cancer Luminaries</em> spotlights the groundbreaking work and visionary leadership shaping cancer care and research at the University of Chicago today. Through conversations with leading faculty, the season highlights the rich history, expertise, and innovation driving progress—while exploring future ambitions as UChicago prepares to open its new Cancer Pavilion. Featuring personal stories and perspectives, this season offers insight into current breakthroughs, evolving approaches to treatment, and the people advancing the field, all while amplifying UChicago’s voice on the national stage.</div>
<p></p>
<p>2024 was the University of Chicago Medicine Comprehensive Cancer Center’s 50th anniversary of National Cancer Institute designation, thus we planned a year full of events to honor our past, communicate our present, and envision our future. Season 1 of <em>Cancer Luminaries</em> Season 1 was our effort to learn more about the lives and careers of our Alumni Stars Lecture Series’ invited guests.</p>]]></description>
    <pubDate>Tue, 23 Jun 2026 09:33:30 -0600</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2024 All rights reserved.</copyright>
    <category>Science</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary></itunes:summary>
        <itunes:author>CFB</itunes:author>
<itunes:category text="Science" />
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
<itunes:category text="Education" />
    <itunes:owner>
        <itunes:name>CFB</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
	<itunes:new-feed-url>https://feed.podbean.com/cancer-luminaries/feed.xml</itunes:new-feed-url>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/17973089/20240222_UCCCC_50th_Cancer-Luminaries-3000x3000_v2_t6jzwh.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/17973089/20240222_UCCCC_50th_Cancer-Luminaries-3000x3000_v2_t6jzwh.jpg</url>
        <title>Cancer Luminaries</title>
        <link>https://cancer-luminaries.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Dr. Soni Smith and Dr. Kay Macleod on Leadership</title>
        <itunes:title>Dr. Soni Smith and Dr. Kay Macleod on Leadership</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-soni-smith-and-dr-kay-macleod-on-leadership/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-soni-smith-and-dr-kay-macleod-on-leadership/#comments</comments>        <pubDate>Tue, 23 Jun 2026 09:33:30 -0600</pubDate>
        <guid isPermaLink="false">cancer-luminaries.podbean.com/6d8e0d97-6411-3a8c-8955-62a7e49f25e6</guid>
                                    <description><![CDATA[<p>This episode centers on how strong, collaborative leadership at the University of Chicago is driving innovation and shaping the future of cancer research and patient care. The conversation explores the personal motivations, day-to-day work, leadership philosophies, and future vision of two prominent cancer leaders: Dr. Sonali Smith (Chief of Hematology Oncology) and Dr. Kay Macleod (Vice Chair, Ben May Department of Cancer Research).</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode centers on how strong, collaborative leadership at the University of Chicago is driving innovation and shaping the future of cancer research and patient care. The conversation explores the personal motivations, day-to-day work, leadership philosophies, and future vision of two prominent cancer leaders: Dr. Sonali Smith (Chief of Hematology Oncology) and Dr. Kay Macleod (Vice Chair, Ben May Department of Cancer Research).</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5p5jf3m85sqg6ypt/Leadership_podcast-edited7637p.mp3" length="80271502" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode centers on how strong, collaborative leadership at the University of Chicago is driving innovation and shaping the future of cancer research and patient care. The conversation explores the personal motivations, day-to-day work, leadership philosophies, and future vision of two prominent cancer leaders: Dr. Sonali Smith (Chief of Hematology Oncology) and Dr. Kay Macleod (Vice Chair, Ben May Department of Cancer Research).]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2453</itunes:duration>
                <itunes:episode>11</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/phiycejty8vb2qyq/880a9e80-029f-3bdf-9cfa-8c7873251556.srt" type="application/srt" />    </item>
    <item>
        <title>Dr. Tan and Dr. Pierce on Environmental/Lifestyle Risks and Cancer Prevention</title>
        <itunes:title>Dr. Tan and Dr. Pierce on Environmental/Lifestyle Risks and Cancer Prevention</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-tan-and-dr-pierce-on-environmentallifestyle-risks-and-cancer-prevention/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-tan-and-dr-pierce-on-environmentallifestyle-risks-and-cancer-prevention/#comments</comments>        <pubDate>Thu, 07 May 2026 15:18:33 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/884d501c-b6fb-3ad0-943f-25507172775d</guid>
                                    <description><![CDATA[<p>In this enlightening episode of Cancer Luminaries Season 2, host Camilla Frost-Brewer is joined by UChicago’s oncology luminaries, Dr. Brandon Pierce and Dr. Marcia Tan, for a deep dive into the world of cancer prevention, environmental risk, and the innovative strategies that are shaping the future of cancer care.</p>
<p>Together, they explore:</p>
<ul>
<li>What drives their passion for cancer research, from family legacies and personal experiences to scientific curiosity.</li>
<li>How their labs and community programs are advancing cancer research—whether by unraveling genetic susceptibility to environmental carcinogens like arsenic, or by empowering underserved groups through tobacco cessation and behavioral interventions.</li>
<li>The critical importance of access: Dr. Tan discusses “gold standard” treatments for tobacco cessation and highlights resources like Courage to Quit at UChicago Medicine and the Illinois Tobacco Quitline.</li>
<li>Dr. Pierce explains groundbreaking interdisciplinary research on arsenic exposure in Bangladesh, genetic risk factors, and the work of key collaborators at UChicago.</li>
<li>The evolving role of environmental and lifestyle factors in cancer prevention, including large-scale cohort studies, exposomic technologies, and innovative policy approaches, both locally and globally.</li>
<li>How UChicago’s cancer program is addressing health disparities through outreach and research that bridges macro data and micro lived experiences—ensuring interventions are shaped with, and for, the community.</li>
</ul>
<p>Looking forward, our guests share their excitement for:</p>
<ul>
<li>Advances in exposomics, mutation signature analysis, and polygenic risk scores for personalized cancer risk prediction and early detection.</li>
<li>The rising role of community health workers and holistic support models for cancer prevention, including responses to new challenges like vaping.</li>
<li>The upcoming Cancer Pavilion at UChicago—featuring dedicated community spaces, patient navigation, survivorship resources, and expanded outreach aimed at making care accessible and personal.</li>
</ul>
<p>This episode is a must-listen for anyone interested in the people, ideas, and collaborations pioneering a future where cancer is preventable, disparities are erased, and every patient has a supportive path to survivorship.</p>
<p>Resources Mentioned:</p>
<ul>
<li><a href='https://uchicagomedicine.org/'>Courage to Quit (UChicago Medicine)</a></li>
<li><a href='https://quitresearch.org/'>Illinois Tobacco Quitline</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this enlightening episode of Cancer Luminaries Season 2, host Camilla Frost-Brewer is joined by UChicago’s oncology luminaries, Dr. Brandon Pierce and Dr. Marcia Tan, for a deep dive into the world of cancer prevention, environmental risk, and the innovative strategies that are shaping the future of cancer care.</p>
<p>Together, they explore:</p>
<ul>
<li>What drives their passion for cancer research, from family legacies and personal experiences to scientific curiosity.</li>
<li>How their labs and community programs are advancing cancer research—whether by unraveling genetic susceptibility to environmental carcinogens like arsenic, or by empowering underserved groups through tobacco cessation and behavioral interventions.</li>
<li>The critical importance of access: Dr. Tan discusses “gold standard” treatments for tobacco cessation and highlights resources like Courage to Quit at UChicago Medicine and the Illinois Tobacco Quitline.</li>
<li>Dr. Pierce explains groundbreaking interdisciplinary research on arsenic exposure in Bangladesh, genetic risk factors, and the work of key collaborators at UChicago.</li>
<li>The evolving role of environmental and lifestyle factors in cancer prevention, including large-scale cohort studies, exposomic technologies, and innovative policy approaches, both locally and globally.</li>
<li>How UChicago’s cancer program is addressing health disparities through outreach and research that bridges macro data and micro lived experiences—ensuring interventions are shaped with, and for, the community.</li>
</ul>
<p>Looking forward, our guests share their excitement for:</p>
<ul>
<li>Advances in exposomics, mutation signature analysis, and polygenic risk scores for personalized cancer risk prediction and early detection.</li>
<li>The rising role of community health workers and holistic support models for cancer prevention, including responses to new challenges like vaping.</li>
<li>The upcoming Cancer Pavilion at UChicago—featuring dedicated community spaces, patient navigation, survivorship resources, and expanded outreach aimed at making care accessible and personal.</li>
</ul>
<p>This episode is a must-listen for anyone interested in the people, ideas, and collaborations pioneering a future where cancer is preventable, disparities are erased, and every patient has a supportive path to survivorship.</p>
<p>Resources Mentioned:</p>
<ul>
<li><a href='https://uchicagomedicine.org/'>Courage to Quit (UChicago Medicine)</a></li>
<li><a href='https://quitresearch.org/'>Illinois Tobacco Quitline</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ppr447rmqsipdmty/Cancer_Luminaries_S2E2_Pierce_Tan.m4a" length="31490742" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this enlightening episode of Cancer Luminaries Season 2, host Camilla Frost-Brewer is joined by UChicago’s oncology luminaries, Dr. Brandon Pierce and Dr. Marcia Tan, for a deep dive into the world of cancer prevention, environmental risk, and the innovative strategies that are shaping the future of cancer care.
Together, they explore:

What drives their passion for cancer research, from family legacies and personal experiences to scientific curiosity.
How their labs and community programs are advancing cancer research—whether by unraveling genetic susceptibility to environmental carcinogens like arsenic, or by empowering underserved groups through tobacco cessation and behavioral interventions.
The critical importance of access: Dr. Tan discusses “gold standard” treatments for tobacco cessation and highlights resources like Courage to Quit at UChicago Medicine and the Illinois Tobacco Quitline.
Dr. Pierce explains groundbreaking interdisciplinary research on arsenic exposure in Bangladesh, genetic risk factors, and the work of key collaborators at UChicago.
The evolving role of environmental and lifestyle factors in cancer prevention, including large-scale cohort studies, exposomic technologies, and innovative policy approaches, both locally and globally.
How UChicago’s cancer program is addressing health disparities through outreach and research that bridges macro data and micro lived experiences—ensuring interventions are shaped with, and for, the community.

Looking forward, our guests share their excitement for:

Advances in exposomics, mutation signature analysis, and polygenic risk scores for personalized cancer risk prediction and early detection.
The rising role of community health workers and holistic support models for cancer prevention, including responses to new challenges like vaping.
The upcoming Cancer Pavilion at UChicago—featuring dedicated community spaces, patient navigation, survivorship resources, and expanded outreach aimed at making care accessible and personal.

This episode is a must-listen for anyone interested in the people, ideas, and collaborations pioneering a future where cancer is preventable, disparities are erased, and every patient has a supportive path to survivorship.
Resources Mentioned:

Courage to Quit (UChicago Medicine)
Illinois Tobacco Quitline
]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2306</itunes:duration>
                <itunes:episode>10</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17973089/20260301_UCCCC_Cancer-Luminaries-Square.png" /><podcast:transcript url="https://mcdn.podbean.com/mf/web/b8ka532bni4n3mqr/b0f7e221-c2a4-3923-8a21-b44dc7e9c5ff.srt" type="application/srt" />    </item>
    <item>
        <title>Dr. Mitchell Posner and Dr. Everett Vokes on UChicago's Legacy in Cancer Research</title>
        <itunes:title>Dr. Mitchell Posner and Dr. Everett Vokes on UChicago's Legacy in Cancer Research</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-mitchell-posner-and-dr-everett-vokes-on-uchicago-history/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-mitchell-posner-and-dr-everett-vokes-on-uchicago-history/#comments</comments>        <pubDate>Thu, 05 Mar 2026 14:40:11 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/cdf1cbce-cdf0-3e51-a04a-d7c7188409de</guid>
                                    <description><![CDATA[<p>Welcome to the second season of Cancer Luminaries, the show where we talk to UChicago oncology leaders who are driving innovation, shaping patient care, and envisioning a future free of cancer. In this episode, host Camilla Frost-Brewer sits down with Drs. Everett Vokes and Mitchell Posner, two of UChicago's distinguished oncology leaders, to discuss UChicago's rich legacy of cancer research and care that has been defined by ground-breaking discoveries, transformative leadership, and a commitment to pushing the field forward. This first episode of Season 2 reflects on that history and explores how it continues to shape today's innovations, including the New Cancer Pavilion, which is set to open in 2027.</p>
<p> </p>
<p>To learn more about UChicago's legacy in cancer research, please visit https://www.uchicagomedicine.org/cancer/about-us/legacy.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to the second season of <em>Cancer Luminaries</em>, the show where we talk to UChicago oncology leaders who are driving innovation, shaping patient care, and envisioning a future free of cancer. In this episode, host Camilla Frost-Brewer sits down with Drs. Everett Vokes and Mitchell Posner, two of UChicago's distinguished oncology leaders, to discuss UChicago's rich legacy of cancer research and care that has been defined by ground-breaking discoveries, transformative leadership, and a commitment to pushing the field forward. This first episode of Season 2 reflects on that history and explores how it continues to shape today's innovations, including the New Cancer Pavilion, which is set to open in 2027.</p>
<p> </p>
<p>To learn more about UChicago's legacy in cancer research, please visit https://www.uchicagomedicine.org/cancer/about-us/legacy.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/az33h6qyhvh6irjm/Vokes_Posner_mixdownsesx_mixdown6ekbk.mp3" length="51773996" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to the second season of Cancer Luminaries, the show where we talk to UChicago oncology leaders who are driving innovation, shaping patient care, and envisioning a future free of cancer. In this episode, host Camilla Frost-Brewer sits down with Drs. Everett Vokes and Mitchell Posner, two of UChicago's distinguished oncology leaders, to discuss UChicago's rich legacy of cancer research and care that has been defined by ground-breaking discoveries, transformative leadership, and a commitment to pushing the field forward. This first episode of Season 2 reflects on that history and explores how it continues to shape today's innovations, including the New Cancer Pavilion, which is set to open in 2027.
 
To learn more about UChicago's legacy in cancer research, please visit https://www.uchicagomedicine.org/cancer/about-us/legacy.]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2156</itunes:duration>
        <itunes:season>2</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17973089/20260301_UCCCC_Cancer-Luminaries-Square.png" /><podcast:transcript url="https://mcdn.podbean.com/mf/web/kfsuc4um3uhdavtt/8cd180a5-1003-3c57-84c4-21899f1657a7.srt" type="application/srt" />    </item>
    <item>
        <title>Dr. Tina Shih on Addressing Cancer’s Financial Burden</title>
        <itunes:title>Dr. Tina Shih on Addressing Cancer’s Financial Burden</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-tina-shih-on-cancer-s-financial-burden/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-tina-shih-on-cancer-s-financial-burden/#comments</comments>        <pubDate>Tue, 17 Dec 2024 13:57:33 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/11ca4d34-0acd-3070-9593-ad10185b8501</guid>
                                    <description><![CDATA[<p>In this episode, host Camilla Frost-Brewer interviews Alumni Star Tina Shih, PhD, Professor of Health Economics and Director of the Program in Cancer Health Economics Research at UCLA Jonsson Comprehensive Cancer Center. Dr. Shih talks about how health economics can tackle various issues across the entire cancer care continuum, from prevention to treatment to survivorship. As newer treatments are developed, health economists like Dr. Shih are analyzing the financial burden on patients and ways to make cancer care more affordable. She also reflects on taking on leadership roles at different stages of her career.</p>
<p>“Starday”
Podington Bear
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, host Camilla Frost-Brewer interviews Alumni Star Tina Shih, PhD, Professor of Health Economics and Director of the Program in Cancer Health Economics Research at UCLA Jonsson Comprehensive Cancer Center. Dr. Shih talks about how health economics can tackle various issues across the entire cancer care continuum, from prevention to treatment to survivorship. As newer treatments are developed, health economists like Dr. Shih are analyzing the financial burden on patients and ways to make cancer care more affordable. She also reflects on taking on leadership roles at different stages of her career.</p>
<p>“Starday”<br>
Podington Bear<br>
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aa2dmeh7psfrdjgb/Tina_Shih_FINAL_mixdown6v7do.mp3" length="37953043" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, host Camilla Frost-Brewer interviews Alumni Star Tina Shih, PhD, Professor of Health Economics and Director of the Program in Cancer Health Economics Research at UCLA Jonsson Comprehensive Cancer Center. Dr. Shih talks about how health economics can tackle various issues across the entire cancer care continuum, from prevention to treatment to survivorship. As newer treatments are developed, health economists like Dr. Shih are analyzing the financial burden on patients and ways to make cancer care more affordable. She also reflects on taking on leadership roles at different stages of her career.
“Starday”Podington Bearsoundofpicture.com/]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1580</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>9</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fireside Chat with Past and Present Directors</title>
        <itunes:title>Fireside Chat with Past and Present Directors</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/cancer-center-luminaries-podcast-fireside-chat-with-past-and-present-directors/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/cancer-center-luminaries-podcast-fireside-chat-with-past-and-present-directors/#comments</comments>        <pubDate>Tue, 24 Sep 2024 12:05:37 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/02f80e5e-b465-30a0-9911-d5d0f52a214e</guid>
                                    <description><![CDATA[<p>In this special episode, Camilla Frost-Brewer held a fireside conversation with two former directors and one current director to learn what it is like to lead a National Cancer Institute-designated Cancer Center and how they approached the opportunities and challenges of the role. Medical oncologist Richard L. Schilsky, MD, Director from 1991 to 1999, drove initiatives to modernize and organize the Cancer Center. Cancer geneticist and cancer biologist Michelle M. Le Beau, PhD, Director from 2004 to 2021, not only helped the Cancer Center achieve Comprehensive status, but she strengthened our programs in population research and community research. Physician-scientist Kunle Odunsi, MD, PhD, Director since 2021, is leveraging resources, advanced technologies and partnerships from across the University network to take a pipeline of discoveries to the clinic where they can make an immediate impact. Together, they reflected on what is unique about the intellectual environment at the University of Chicago and predicted where cancer research is going next.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p><em>In this special episode, Camilla Frost-Brewer held a fireside conversation with two former directors and one current director to learn what it is like to lead a National Cancer Institute-designated Cancer Center and how they approached the opportunities and challenges of the role. Medical oncologist Richard L. Schilsky, MD, Director from 1991 to 1999, drove initiatives to modernize and organize the Cancer Center. Cancer geneticist and cancer biologist Michelle M. Le Beau, PhD, Director from 2004 to 2021, not only helped the Cancer Center achieve Comprehensive status, but she strengthened our programs in population research and community research. Physician-scientist Kunle Odunsi, MD, PhD, Director since 2021, is leveraging resources, advanced technologies and partnerships from across the University network to take a pipeline of discoveries to the clinic where they can make an immediate impact. Together, they reflected on what is unique about the intellectual environment at the University of Chicago and predicted where cancer research is going next.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2djwm4sv5k29cknj/Cancer_Center_Luminaries_Podcast_Audio_vFinal914vj.mp3" length="133480012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this special episode, Camilla Frost-Brewer held a fireside conversation with two former directors and one current director to learn what it is like to lead a National Cancer Institute-designated Cancer Center and how they approached the opportunities and challenges of the role. Medical oncologist Richard L. Schilsky, MD, Director from 1991 to 1999, drove initiatives to modernize and organize the Cancer Center. Cancer geneticist and cancer biologist Michelle M. Le Beau, PhD, Director from 2004 to 2021, not only helped the Cancer Center achieve Comprehensive status, but she strengthened our programs in population research and community research. Physician-scientist Kunle Odunsi, MD, PhD, Director since 2021, is leveraging resources, advanced technologies and partnerships from across the University network to take a pipeline of discoveries to the clinic where they can make an immediate impact. Together, they reflected on what is unique about the intellectual environment at the University of Chicago and predicted where cancer research is going next.]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>5375</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>8</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Angela Bradbury and the Power of Genetic Testing to Improve Health</title>
        <itunes:title>Dr. Angela Bradbury and the Power of Genetic Testing to Improve Health</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-angela-bradbury-and-the-power-of-genetic-testing-to-improve-health/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-angela-bradbury-and-the-power-of-genetic-testing-to-improve-health/#comments</comments>        <pubDate>Tue, 10 Sep 2024 11:02:31 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/a481f816-3ab5-3b64-87ff-83dc4f2987b1</guid>
                                    <description><![CDATA[<p>Host Camilla Frost-Brewer has a conversation with Alumni Star Angela Bradbury, MD, Associate Professor of  Medicine at the University of Pennsylvania Abramson Cancer Center. Dr. Bradbury is a medical oncologist with specialized training in clinical cancer genetics, cancer prevention and medical ethics. Her research focuses on integrating genetic medicine into the clinic to reduce the burden of cancer and improve the health of individuals and families. In 2012, she started the Penn Telegenetics Program based on research evaluating remote phone and real-time services for cancer genetic counseling and testing. In this episode, she explains how technology has enable greater access to genetic counseling for people in the community. She also repeats the career advice that keeps her grounded, including the importance of saying “no” to avoid overextending yourself.</p>
<p> </p>
<p>“Starday”
Podington Bear
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host Camilla Frost-Brewer has a conversation with Alumni Star Angela Bradbury, MD, Associate Professor of  Medicine at the University of Pennsylvania Abramson Cancer Center. Dr. Bradbury is a medical oncologist with specialized training in clinical cancer genetics, cancer prevention and medical ethics. Her research focuses on integrating genetic medicine into the clinic to reduce the burden of cancer and improve the health of individuals and families. In 2012, she started the Penn Telegenetics Program based on research evaluating remote phone and real-time services for cancer genetic counseling and testing. In this episode, she explains how technology has enable greater access to genetic counseling for people in the community. She also repeats the career advice that keeps her grounded, including the importance of saying “no” to avoid overextending yourself.</p>
<p> </p>
<p>“Starday”<br>
Podington Bear<br>
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/breuw9my682jgw73/Bradbury_mixdown_mixdown.mp3" length="50153957" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host Camilla Frost-Brewer has a conversation with Alumni Star Angela Bradbury, MD, Associate Professor of  Medicine at the University of Pennsylvania Abramson Cancer Center. Dr. Bradbury is a medical oncologist with specialized training in clinical cancer genetics, cancer prevention and medical ethics. Her research focuses on integrating genetic medicine into the clinic to reduce the burden of cancer and improve the health of individuals and families. In 2012, she started the Penn Telegenetics Program based on research evaluating remote phone and real-time services for cancer genetic counseling and testing. In this episode, she explains how technology has enable greater access to genetic counseling for people in the community. She also repeats the career advice that keeps her grounded, including the importance of saying “no” to avoid overextending yourself.
 
“Starday”Podington Bearsoundofpicture.com/]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2089</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>7</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Stefani Spranger on Moving the Field Forward</title>
        <itunes:title>Dr. Stefani Spranger on Moving the Field Forward</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-stefani-spranger-on-moving-the-field-forward/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-stefani-spranger-on-moving-the-field-forward/#comments</comments>        <pubDate>Thu, 29 Aug 2024 07:49:05 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/27ceef3c-f4c6-3db0-90b1-c1401abfd3fe</guid>
                                    <description><![CDATA[<p>Host Camilla Frost-Brewer gets to know Alumni Star and cancer immunologist Stefani Spranger, PhD, Associate Professor of Biology at the Koch Institute for Integrative Biology at MIT. Dr. Spranger studies how the body’s immune system interacts with growing tumors to harness the immune response to fight cancer. In this episode, she recounts how a mind-blowing paper led her to a career in cancer immunology and the advantages of being an immunologist surrounded by cancer biologists and engineers. She also talks about the collaborative nature of scientific research in the United States, the joy of seeing a mentee blossom, and learning to trust that you are doing enough at home and at work.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host Camilla Frost-Brewer gets to know Alumni Star and cancer immunologist Stefani Spranger, PhD, Associate Professor of Biology at the Koch Institute for Integrative Biology at MIT. Dr. Spranger studies how the body’s immune system interacts with growing tumors to harness the immune response to fight cancer. In this episode, she recounts how a mind-blowing paper led her to a career in cancer immunology and the advantages of being an immunologist surrounded by cancer biologists and engineers. She also talks about the collaborative nature of scientific research in the United States, the joy of seeing a mentee blossom, and learning to trust that you are doing enough at home and at work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c6fh2xu7tj367tpv/Spranger_mixdown.mp3" length="31326739" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host Camilla Frost-Brewer gets to know Alumni Star and cancer immunologist Stefani Spranger, PhD, Associate Professor of Biology at the Koch Institute for Integrative Biology at MIT. Dr. Spranger studies how the body’s immune system interacts with growing tumors to harness the immune response to fight cancer. In this episode, she recounts how a mind-blowing paper led her to a career in cancer immunology and the advantages of being an immunologist surrounded by cancer biologists and engineers. She also talks about the collaborative nature of scientific research in the United States, the joy of seeing a mentee blossom, and learning to trust that you are doing enough at home and at work.]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1304</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>6</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/7rjqpc7ft8zitqpd/d9ee68c6-2500-3b0d-9365-67d41700b2be.srt" type="application/srt" />    </item>
    <item>
        <title>Dr. Huiping Liu on Following Your Passion</title>
        <itunes:title>Dr. Huiping Liu on Following Your Passion</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/episode-5-dr-huiping-liu-on-following-your-passion/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/episode-5-dr-huiping-liu-on-following-your-passion/#comments</comments>        <pubDate>Mon, 22 Jul 2024 13:40:24 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/9e42a50e-6254-349f-91f4-20044f71fc81</guid>
                                    <description><![CDATA[


<p class="first">Host Camilla Frost-Brewer spends time with Alumni Star and translational cancer researcher Huiping Liu, MD, PhD, Associate Professor of Pharmacology and Medicine at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center. Dr. Liu leads a cross-disciplinary team that uses advanced technologies to investigate the root causes of cancer. In this episode, she shares how a favorite teacher’s cancer diagnosis launched her personal mission to cure cancer. She also shares her tips for cultivating a lab culture that prioritizes passion, collaboration, innovation and compassion and maintaining a positive attitude through all problem-solving.</p>
<p class="first"> </p>
<p class="first"> </p>
<p>“Starday”
Podington Bear
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>




]]></description>
                                                            <content:encoded><![CDATA[


<p class="first">Host Camilla Frost-Brewer spends time with Alumni Star and translational cancer researcher Huiping Liu, MD, PhD, Associate Professor of Pharmacology and Medicine at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center. Dr. Liu leads a cross-disciplinary team that uses advanced technologies to investigate the root causes of cancer. In this episode, she shares how a favorite teacher’s cancer diagnosis launched her personal mission to cure cancer. She also shares her tips for cultivating a lab culture that prioritizes passion, collaboration, innovation and compassion and maintaining a positive attitude through all problem-solving.</p>
<p class="first"> </p>
<p class="first"> </p>
<p>“Starday”<br>
Podington Bear<br>
<a href='https://www.soundofpicture.com/'>soundofpicture.com/</a></p>




]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xabtkivtrnhuz2h3/Liu_Final_mixdown.mp3" length="35628409" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Host Camilla Frost-Brewer spends time with Alumni Star and translational cancer researcher Huiping Liu, MD, PhD, Associate Professor of Pharmacology and Medicine at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center. Dr. Liu leads a cross-disciplinary team that uses advanced technologies to investigate the root causes of cancer. In this episode, she shares how a favorite teacher’s cancer diagnosis launched her personal mission to cure cancer. She also shares her tips for cultivating a lab culture that prioritizes passion, collaboration, innovation and compassion and maintaining a positive attitude through all problem-solving.
 
 
“Starday”Podington Bearsoundofpicture.com/




]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1484</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>5</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Suzanne Conzen on Approaching Problems from the Micro to the Macro Level</title>
        <itunes:title>Dr. Suzanne Conzen on Approaching Problems from the Micro to the Macro Level</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-suzanne-conzen-on-approaching-problems-from-the-micro-to-the-macro-level/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-suzanne-conzen-on-approaching-problems-from-the-micro-to-the-macro-level/#comments</comments>        <pubDate>Fri, 19 Jul 2024 11:42:32 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/4d83d1b3-7d97-3aa6-81a5-480e82640c7c</guid>
                                    <description><![CDATA[<p>Camilla Frost-Brewer is joined by Alumni Star and visionary translational researcher, Dr. Suzanne Conzen, who discovered the role of the stress hormone receptor, glucocorticoid receptor, in driving particularly aggressive breast cancers. Dr. Conzen, who is the Chief of the Hematology and Oncology Division at UT Southwestern Harold C. Simmons Comprehensive Cancer Center in Dallas, reflects on her time at UChicago where her work on nuclear hormone receptors led to improvements in cancer care—especially for underserved populations disproportionately affected by triple-negative breast cancer. She describes her encounters with serendipity and the value of looking at a problem from the micro to the macro levels. 

</p>



<p><a href='https://voices.uchicago.edu/cancerresearchtraining/files/2024/07/Conzen-Episode-Transcript.pdf'>Access the full transcript here</a>. This transcript for this episode was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p>“Starday”
Podington Bear
https://www.soundofpicture.com/</p>


]]></description>
                                                            <content:encoded><![CDATA[<p>Camilla Frost-Brewer is joined by Alumni Star and visionary translational researcher, Dr. Suzanne Conzen, who discovered the role of the stress hormone receptor, glucocorticoid receptor, in driving particularly aggressive breast cancers. Dr. Conzen, who is the Chief of the Hematology and Oncology Division at UT Southwestern Harold C. Simmons Comprehensive Cancer Center in Dallas, reflects on her time at UChicago where her work on nuclear hormone receptors led to improvements in cancer care—especially for underserved populations disproportionately affected by triple-negative breast cancer. She describes her encounters with serendipity and the value of looking at a problem from the micro to the macro levels. <br>
<br>
</p>



<p><a href='https://voices.uchicago.edu/cancerresearchtraining/files/2024/07/Conzen-Episode-Transcript.pdf'>Access the full transcript here</a>. This transcript for this episode was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p>“Starday”<br>
Podington Bear<br>
https://www.soundofpicture.com/</p>


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ctb27qwd6gs2gpgh/Conzen_Mixdown_1bsem8.mp3" length="45193793" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Camilla Frost-Brewer is joined by Alumni Star and visionary translational researcher, Dr. Suzanne Conzen, who discovered the role of the stress hormone receptor, glucocorticoid receptor, in driving particularly aggressive breast cancers. Dr. Conzen, who is the Chief of the Hematology and Oncology Division at UT Southwestern Harold C. Simmons Comprehensive Cancer Center in Dallas, reflects on her time at UChicago where her work on nuclear hormone receptors led to improvements in cancer care—especially for underserved populations disproportionately affected by triple-negative breast cancer. She describes her encounters with serendipity and the value of looking at a problem from the micro to the macro levels. 



Access the full transcript here. This transcript for this episode was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.
 
“Starday”Podington Bearhttps://www.soundofpicture.com/


]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1882</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Charles Rudin Talks about Sitting on the Fence of Science and Medicine</title>
        <itunes:title>Dr. Charles Rudin Talks about Sitting on the Fence of Science and Medicine</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-charles-rudin-talks-about-sitting-on-the-fence-of-science-and-medicine/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-charles-rudin-talks-about-sitting-on-the-fence-of-science-and-medicine/#comments</comments>        <pubDate>Thu, 16 May 2024 15:17:46 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/b2ca8f28-2aad-3716-96cc-aa2995bef114</guid>
                                    <description><![CDATA[<p>Camilla Frost-Brewer talks with star alumnus Charles Rudin, MD, PhD, deputy director of Memorial Sloan-Kettering Cancer Center and thoracic oncologist, about choosing a career path that allowed him to sit on the fence between science and medicine. He also reminisced about how his career has been shaped by his time at the University of Chicago, working alongside mentors who taught him to think critically and creatively. He marveled at the transformation of lung cancer into a survivable disease and predicts that cancer is something we will live with but get better at controlling.</p>
<p> </p>
<p> </p>
<p><a href='https://voices.uchicago.edu/cancercenterdei/files/2024/05/Rudin-Episode_Transcript.pdf'>Access the full transcript here.</a> This transcript for Episode 3: Dr. Charles Rudin Talks about Sitting on the Fence of Science and Medicine was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p><a href='https://www.soundofpicture.com/'>https://www.soundofpicture.com/</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Camilla Frost-Brewer talks with star alumnus Charles Rudin, MD, PhD, deputy director of Memorial Sloan-Kettering Cancer Center and thoracic oncologist, about choosing a career path that allowed him to sit on the fence between science and medicine. He also reminisced about how his career has been shaped by his time at the University of Chicago, working alongside mentors who taught him to think critically and creatively. He marveled at the transformation of lung cancer into a survivable disease and predicts that cancer is something we will live with but get better at controlling.</p>
<p> </p>
<p> </p>
<p><a href='https://voices.uchicago.edu/cancercenterdei/files/2024/05/Rudin-Episode_Transcript.pdf'>Access the full transcript here.</a> This transcript for Episode 3: Dr. Charles Rudin Talks about Sitting on the Fence of Science and Medicine was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p><a href='https://www.soundofpicture.com/'>https://www.soundofpicture.com/</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h3q26ghrwnyezw3r/Rudin_Episode_Final_Mixdown_mixdown6gsj9.mp3" length="47029660" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Camilla Frost-Brewer talks with star alumnus Charles Rudin, MD, PhD, deputy director of Memorial Sloan-Kettering Cancer Center and thoracic oncologist, about choosing a career path that allowed him to sit on the fence between science and medicine. He also reminisced about how his career has been shaped by his time at the University of Chicago, working alongside mentors who taught him to think critically and creatively. He marveled at the transformation of lung cancer into a survivable disease and predicts that cancer is something we will live with but get better at controlling.
 
 
Access the full transcript here. This transcript for Episode 3: Dr. Charles Rudin Talks about Sitting on the Fence of Science and Medicine was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.
 
 
 
“Starday”
Podington Bear
https://www.soundofpicture.com/ ]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1959</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Otis Brawley Talks about Cancer Disparities as Barriers to Better Outcomes for All</title>
        <itunes:title>Dr. Otis Brawley Talks about Cancer Disparities as Barriers to Better Outcomes for All</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/dr-otis-brawley-talks-about-cancer-disparities-as-barriers-to-better-outcomes-for-all/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/dr-otis-brawley-talks-about-cancer-disparities-as-barriers-to-better-outcomes-for-all/#comments</comments>        <pubDate>Thu, 25 Apr 2024 08:46:56 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/f33a868f-56a5-33b4-b5ff-a99c42c01d8b</guid>
                                    <description><![CDATA[<p>This episode features alumni star and nationally renowned cancer disparities researcher Otis W. Brawley, SB’81, MD’85, the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He recounts his “Forrest Gump existence,” where he was in the room when big moments happened. Dr. Brawley grew up in Detroit and completed undergraduate and medical training at the University of Chicago, where he says he met giants of cancer, Dr. John Ultmann and Dr. Harvey Golub. These early experiences with mentors set the course for Dr. Brawley’s career where he has been able to make a difference in improving outcomes for cancer patients through his research, advocacy, and mentorship of young cancer researchers from underrepresented backgrounds.</p>
<p> </p>
<p>Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.</p>
<p> </p>
<p><a href='https://voices.uchicago.edu/ucccc50/files/2024/04/Brawley-Episode_Transcript-e1425fd7389736b6.pdf'>Access the full transcript here</a>. This transcript for Episode 2: Dr. Otis Brawley Talks about Cancer Disparities as Barriers to Better Outcomes for All was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p><a href='https://www.soundofpicture.com/'>https://www.soundofpicture.com/</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features alumni star and nationally renowned cancer disparities researcher Otis W. Brawley, SB’81, MD’85, the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He recounts his “Forrest Gump existence,” where he was in the room when big moments happened. Dr. Brawley grew up in Detroit and completed undergraduate and medical training at the University of Chicago, where he says he met giants of cancer, Dr. John Ultmann and Dr. Harvey Golub. These early experiences with mentors set the course for Dr. Brawley’s career where he has been able to make a difference in improving outcomes for cancer patients through his research, advocacy, and mentorship of young cancer researchers from underrepresented backgrounds.</p>
<p> </p>
<p>Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.</p>
<p> </p>
<p><a href='https://voices.uchicago.edu/ucccc50/files/2024/04/Brawley-Episode_Transcript-e1425fd7389736b6.pdf'>Access the full transcript here</a>. This transcript for Episode 2: Dr. Otis Brawley Talks about Cancer Disparities as Barriers to Better Outcomes for All was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p><a href='https://www.soundofpicture.com/'>https://www.soundofpicture.com/</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7yhjmukchp3ueha2/Brawley_Final_Mixdown_mixdown6ytm8.mp3" length="56056303" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features alumni star and nationally renowned cancer disparities researcher Otis W. Brawley, SB’81, MD’85, the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He recounts his “Forrest Gump existence,” where he was in the room when big moments happened. Dr. Brawley grew up in Detroit and completed undergraduate and medical training at the University of Chicago, where he says he met giants of cancer, Dr. John Ultmann and Dr. Harvey Golub. These early experiences with mentors set the course for Dr. Brawley’s career where he has been able to make a difference in improving outcomes for cancer patients through his research, advocacy, and mentorship of young cancer researchers from underrepresented backgrounds.
 
Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.
 
Access the full transcript here. This transcript for Episode 2: Dr. Otis Brawley Talks about Cancer Disparities as Barriers to Better Outcomes for All was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.
 
 
 
“Starday”
Podington Bear
https://www.soundofpicture.com/ ]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2335</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dr. Todd Golub Talks about Maximizing Your Impact on the World through Bold Science</title>
        <itunes:title>Dr. Todd Golub Talks about Maximizing Your Impact on the World through Bold Science</itunes:title>
        <link>https://cancer-luminaries.podbean.com/e/golub/</link>
                    <comments>https://cancer-luminaries.podbean.com/e/golub/#comments</comments>        <pubDate>Wed, 17 Apr 2024 11:24:56 -0600</pubDate>
        <guid isPermaLink="false">ucccc50.podbean.com/116b90d1-e5fe-381b-8670-afcdf9a9281f</guid>
                                    <description><![CDATA[<p>The debut episode of the Cancer Luminaries podcast features alumni star Todd Golub, MD, founding faculty member and now director of the Broad Institute of MIT and Harvard. Dr. Golub is a world leader in applying genomic tools to cancer research, having made important discoveries in the molecular basis of childhood leukemia. He talks about the emotionally intense moments of his training that inspired him to become a cancer researcher and the lessons he took from working with legendary minds at UChicago. Throughout his career, Dr. Golub has fostered interdisciplinary research that has led to truly powerful collaborations. He also encourages scientists to push the biggest, boldest, riskiest ideas forward to make a truly important contribution to the field.</p>
<p> </p>
<p>Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.</p>
<p> </p>
<p><a href='https://voices.uchicago.edu/ucccc50/files/2024/04/Golub-Episode_Transcript-c5492774b4bc08e4.pdf'>Access the full transcript here</a>. This transcript for Episode 1: Dr. Todd Golub Talks about Maximizing Your Impact on the World through Bold Science was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p>https://www.soundofpicture.com/</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The debut episode of the Cancer Luminaries podcast features alumni star Todd Golub, MD, founding faculty member and now director of the Broad Institute of MIT and Harvard. Dr. Golub is a world leader in applying genomic tools to cancer research, having made important discoveries in the molecular basis of childhood leukemia. He talks about the emotionally intense moments of his training that inspired him to become a cancer researcher and the lessons he took from working with legendary minds at UChicago. Throughout his career, Dr. Golub has fostered interdisciplinary research that has led to truly powerful collaborations. He also encourages scientists to push the biggest, boldest, riskiest ideas forward to make a truly important contribution to the field.</p>
<p> </p>
<p>Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.</p>
<p> </p>
<p><a href='https://voices.uchicago.edu/ucccc50/files/2024/04/Golub-Episode_Transcript-c5492774b4bc08e4.pdf'>Access the full transcript here</a>. This transcript for Episode 1: Dr. Todd Golub Talks about Maximizing Your Impact on the World through Bold Science was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.</p>
<p> </p>
<p> </p>
<p> </p>
<p>“Starday”</p>
<p>Podington Bear</p>
<p>https://www.soundofpicture.com/</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xw99q795xz7k7uwd/Golub_Final_Mixdown_mixdownbai2x.mp3" length="47667347" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The debut episode of the Cancer Luminaries podcast features alumni star Todd Golub, MD, founding faculty member and now director of the Broad Institute of MIT and Harvard. Dr. Golub is a world leader in applying genomic tools to cancer research, having made important discoveries in the molecular basis of childhood leukemia. He talks about the emotionally intense moments of his training that inspired him to become a cancer researcher and the lessons he took from working with legendary minds at UChicago. Throughout his career, Dr. Golub has fostered interdisciplinary research that has led to truly powerful collaborations. He also encourages scientists to push the biggest, boldest, riskiest ideas forward to make a truly important contribution to the field.
 
Audio editing provided by Kat Carlton, Senior Marketing and Communications Specialist at UChicago Medicine.
 
Access the full transcript here. This transcript for Episode 1: Dr. Todd Golub Talks about Maximizing Your Impact on the World through Bold Science was prepared by a transcription service and edited by an individual. This version may not be in its final form and may be updated.
 
 
 
“Starday”
Podington Bear
https://www.soundofpicture.com/]]></itunes:summary>
        <itunes:author>CFB</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1985</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
